Holen Sie sich die Stockscreener-App
18.84
0.40%
-0.07
Schlusskurs vom Vortag:
$18.91
Offen:
$19.788
24-Stunden-Volumen:
1.31M
Relative Volume:
0.40
Marktkapitalisierung:
$5.37B
Einnahmen:
$1.19B
Nettoeinkommen (Verlust:
$117.80M
KGV:
45.92
EPS:
0.4103
Netto-Cashflow:
$92.48M
1W Leistung:
+5.46%
1M Leistung:
+4.52%
6M Leistung:
+6.11%
1J Leistung:
+67.87%
1-Tages-Spanne:
$18.74
$19.79
1-Wochen-Bereich:
$17.77
$19.79
52-Wochen-Spanne:
$12.95
$19.85
Sotera Health Co Stock (SHC) Company Profile
Firmenname
Sotera Health Co
Sektor
Branche
Telefon
440-262-1410
Adresse
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
18.84 | 4.92B | 1.19B | 117.80M | 92.48M | 0.4103 |
TMO
Thermo Fisher Scientific Inc
|
587.54 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.95 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
589.31 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
319.10 | 36.95B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
144.80 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-12-18 | Eingeleitet | William Blair | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-05-05 | Hochstufung | Goldman | Neutral → Buy |
| 2024-12-06 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Eingeleitet | Piper Sandler | Neutral |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-03-25 | Hochstufung | Jefferies | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-01-11 | Hochstufung | Barclays | Underweight → Overweight |
| 2023-01-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-09-20 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-03-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-03-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Sotera Health Co Aktie (SHC) Neueste Nachrichten
Sotera Health Co (SHC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SHC|Sotera Health Co|Price:17.350|Chg%:-0.140 - TradingKey
Sotera Health Co (SHC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
Sotera Health Co (SHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sotera Health Company (SHC) Stock forecasts - Yahoo Finance UK
Sotera Health Company (SHC) Stock Analysis: Unpacking A 17.36% Potential Upside - DirectorsTalk Interviews
ETFs Investing in Sotera Health Company Stocks - TradingView
Sotera Health sets Q2 2026 earnings release for August 6 - scanx.trade
Sotera Health Plans 9 a.m. Webcast for Aug. 6 Results - Stock Titan
Sotera Health to report Q2 results, host conference call - Bitget
Sotera Health Company (SHC) Stock Forecasts - Yahoo Finance
Statutory Profit Doesn't Reflect How Good Sotera Health's (NASDAQ:SHC) Earnings Are - 富途牛牛
Sotera Health Co (SHC) Stock Up 5.2% but GF Value Says Overvalued -- GF Score: 74/100 - GuruFocus
How Investors Are Reacting To Sotera Health (SHC) Being Dropped From Key Russell Growth Indices - simplywall.st
3 Reasons SHC is Risky and 1 Stock to Buy Instead - Yahoo Finance
Sotera Health (SHC) Could Be 12% Undervalued As Russell Index Removal Stirs Volatility - simplywall.st
Sotera Health stock edges higher. MarketBeat highlights extended-hours gains - ad-hoc-news.de
Is Sotera Health Company (SHC) A Good Stock To Buy Now? - Yahoo Finance
Sotera Health Co (SHC) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Sotera Health shares, sector peers and risk management in focus - ad-hoc-news.de
Sotera Health Co (SHC) Valuation: PE, PB & Fair Value Analysis - TradingKey
SHC Maintained by Barclays -- Price Target Raised to $19.00 - GuruFocus
Sotera Health Co (SHC) Institutional Confidence - TradingKey
Sotera Health Co (SHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sotera Health Co (SHC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sotera Health Co Stock (US8293551086): Earnings Metrics In Focus After Recent Quarterly Update - AD HOC NEWS
Sotera Health (SHC) Valuation After Goldman Coverage Legal Clarity And Earnings Beat - simplywall.st
Sotera Health Co stock (US8293551086): investors eye litigation overhang and growth in sterilization - AD HOC NEWS
Did Goldman Sachs’ Legal-Risk Reassessment Just Shift Sotera Health's (SHC) Investment Narrative? - simplywall.st
SHC Initiates Coverage On by Goldman Sachs -- Price Target Annou - GuruFocus
Goldman Sachs initiates Sotera Health stock with buy rating on durable model - Investing.com
Sotera Health Co stock (US8293551086): Nasdaq-listed sterilization group in focus after recent earni - AD HOC NEWS
SHCSotera Health Co Forecast, Target Price - Finviz
Sotera Health (SHC) director Ann R. Klee granted 14,970 RSUs as equity award - Stock Titan
Sotera Health (SHC) CEO awarded large RSU and performance SAU grants - Stock Titan
Sotera Health (NYSE: SHC) CEO Alton Shader files initial insider Form 3 - Stock Titan
Sotera Health (SHC) director awarded 14,970 RSUs as equity compensation - Stock Titan
Sotera Health (SHC) director Sean Cunningham receives 14,970 RSU equity grant - Stock Titan
Sotera Health (SHC) director Karen Flynn granted 14,970 RSUs as board compensation - Stock Titan
Sotera Health (SHC) director receives 14,970 RSUs in equity grant - Stock Titan
Sotera Health (SHC) awards 14,970 RSUs to director Vincent Petrella - Stock Titan
Sotera Health (SHC) director gets 14,970 RSUs, now holds 95,751 - Stock Titan
Sotera Health (SHC) director Christopher Simon receives 14,970 RSU award - Stock Titan
Sotera Health (SHC) director awarded 14,970 RSUs, now holds 89,882 shares - Stock Titan
The Bull Case For Sotera Health (SHC) Could Change Following Term Loan Refinancing At Lower Interest Margin - Yahoo Finance
A Look At Sotera Health (SHC) Valuation After Strong Q1 Beat And Upgraded Full Year Outlook - Yahoo Finance
Sotera Health’s SWOT analysis: legal wins reshape stock outlook By Investing.com - Investing.com Canada
Sotera Health’s SWOT analysis: legal wins reshape stock outlook - Investing.com
Sotera Health names new CEO in planned leadership transition - MSN
Sotera Health shareholders elect directors and approve executive pay at annual meeting - Investing.com Australia
Finanzdaten der Sotera Health Co-Aktie (SHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sotera Health Co-Aktie (SHC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| WARBURG PINCUS & CO. | Director |
May 13 '26 |
Sale |
15.17 |
19,102,952 |
289,753,576 |
0 |
| GTCR INVESTMENT XI LLC | Director |
May 13 '26 |
Sale |
15.17 |
12,735,301 |
193,169,046 |
0 |
| WARBURG PINCUS & CO. | Director |
Mar 06 '26 |
Sale |
15.27 |
15,000,000 |
229,050,000 |
19,102,952 |
| WARBURG PINCUS & CO. | Director |
Mar 06 '26 |
Sale |
15.27 |
15,000,000 |
229,050,000 |
19,102,952 |
| GTCR INVESTMENT XI LLC | Director |
Mar 06 '26 |
Sale |
15.27 |
10,000,000 |
152,700,000 |
12,735,301 |
| Petras Michael B. Jr. | Chairman & CEO |
Dec 08 '25 |
Sale |
16.45 |
434,104 |
7,141,011 |
0 |
| Petras Michael B. Jr. | Chairman & CEO |
Dec 08 '25 |
Sale |
16.45 |
315,896 |
5,196,489 |
552,790 |
0.06%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):